Literature DB >> 20350520

Differences in intravascular ultrasound findings in culprit lesions in infarct-related arteries between ST segment elevation myocardial infarction and non-ST segment elevation myocardial infarction.

Young Joon Hong1, Myung Ho Jeong, Yun Ha Choi, Eun Hae Ma, Jum Suk Ko, Min Goo Lee, Keun Ho Park, Doo Sun Sim, Nam Sik Yoon, Hyun Ju Youn, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang.   

Abstract

BACKGROUND: Previous studies have reported diffuse destabilization of atherosclerotic plaques in acute myocardial infarction (AMI). We used intravascular ultrasound (IVUS) to assess coronary culprit lesions in ST segment elevation MI (STEMI) vs. in non-ST segment elevation MI (NSTEMI).
METHODS: Patient population comprised 125 STEMI and 185 NSTEMI patients. IVUS findings included ruptured plaque (a cavity that communicated with the lumen with an overlying residual fibrous cap fragment), lipid-pool like image (a pooling of hypoechoic or echolucent material covered with a hyperechoic layer), thrombus (discrete intraluminal filling defects), and plaque prolapse (tissue extrusion through the stent strut at post-stenting).
RESULTS: Culprit lesions had larger external elastic membrane area (13.5+/-4.9mm(2) vs. 11.9+/-4.3mm(2), p=0.002), larger plaque plus media area (10.8+/-4.4mm(2) vs. 9.1+/-4.1mm(2), p=0.001), and greater plaque burden (78.7+/-10.1% vs. 74.8+/-12.0%, p=0.002), and smaller culprit lesion site calcium arc (96+/-90 degrees vs. 153+/-114 degrees , p=0.002) in patients with STEMI than in those with NSTEMI. Culprit lesion plaque ruptures, lipid-pool like images, and thrombus were observed more frequently in patients with STEMI than in those with NSTEMI (46% vs. 29%, p=0.002; 39% vs. 25%, p=0.010; and 34% vs. 21%, p=0.006, respectively). Culprit lesions were more predominantly hypoechoic in patients with STEMI than in those with NSTEMI (62% vs. 40%, p<0.001). There was a trend that post-stenting plaque prolapse was observed more frequently in patients with STEMI than in those with NSTEMI (33% vs. 24%, p=0.081).
CONCLUSIONS: Culprit lesions in STEMI have more markers of plaque instability (more plaque rupture and thrombus, and larger plaque mass) compared with lesions in NSTEMI. Copyright 2010 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20350520     DOI: 10.1016/j.jjcc.2010.01.010

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  13 in total

1.  Optical coherence tomography features of angiographic complex and smooth lesions in acute coronary syndromes.

Authors:  Hesham Refaat; Giampaolo Niccoli; Mario Gramegna; Rocco A Montone; Francesco Burzotta; Antonio M Leone; Carlo Trani; Ahmed S Ammar; Islam A Elsherbiny; Giancarla Scalone; Francesco Prati; Filippo Crea
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-28       Impact factor: 2.357

2.  Impact of spotty calcification on long-term prediction of future revascularization: a prospective three-vessel intravascular ultrasound study.

Authors:  Hiroto Tamaru; Kenichi Fujii; Masashi Fukunaga; Takahiro Imanaka; Kojiro Miki; Tetsuo Horimatsu; Machiko Nishimura; Ten Saita; Akinori Sumiyoshi; Masahiko Shibuya; Yoshiro Naito; Tohru Masuyama
Journal:  Heart Vessels       Date:  2015-05-12       Impact factor: 2.037

3.  Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction.

Authors:  Yoshiyuki Okuya; Yuichi Saito; Yoshiaki Sakai; Iwao Ishibashi; Yoshio Kobayashi
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-16       Impact factor: 2.357

4.  Postpartum spontaneous coronary dissection presenting with ventricular fibrillation.

Authors:  Daniel Addison; Jonathan Brammer; Swapna Gupta; Nasser Lakkis
Journal:  J Cardiol Cases       Date:  2010-12-21

5.  Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction.

Authors:  Noriaki Tabata; Daisuke Sueta; Tomonori Akasaka; Yuichiro Arima; Kenji Sakamoto; Eiichiro Yamamoto; Yasuhiro Izumiya; Megumi Yamamuro; Kenichi Tsujita; Sunao Kojima; Koichi Kaikita; Kazunori Morita; Kentaro Oniki; Junji Saruwatari; Kazuko Nakagawa; Seiji Hokimoto
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

6.  Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes.

Authors:  Helmy Hassan Elghawaby; Mohamed Ashraf Shawky; Ahmed Hossam Mowafi; Akram Mohamed Abd-Elbary; Farouk Mostafa Faris
Journal:  Egypt Heart J       Date:  2017-06-16

Review 7.  Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction.

Authors:  Young Joon Hong; Youngkeun Ahn; Myung Ho Jeong
Journal:  Korean Circ J       Date:  2015-07-16       Impact factor: 3.243

8.  Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes.

Authors:  Mohamed Farag; Diana A Gorog; Abhiram Prasad; Manivannan Srinivasan
Journal:  Open Heart       Date:  2015-10-01

9.  Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population.

Authors:  Perttu P Salo; Satu Vaara; Johannes Kettunen; Matti Pirinen; Antti-Pekka Sarin; Heikki Huikuri; Pekka J Karhunen; Markku Eskola; Kjell Nikus; Marja-Liisa Lokki; Samuli Ripatti; Aki S Havulinna; Veikko Salomaa; Aarno Palotie; Markku S Nieminen; Juha Sinisalo; Markus Perola
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

10.  Myocardial infarction, ST-elevation and non-ST-elevation myocardial infarction and modelled daily pollution concentrations: a case-crossover analysis of MINAP data.

Authors:  Barbara K Butland; Richard W Atkinson; Ai Milojevic; Mathew R Heal; Ruth M Doherty; Ben G Armstrong; Ian A MacKenzie; Massimo Vieno; Chun Lin; Paul Wilkinson
Journal:  Open Heart       Date:  2016-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.